JRSIS Health Care Corporation (JRSS)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 36 | 44 | 0 | 3 | 1 | 0 | 0 | - |
| Operating profit | $m | 0 | -0 | ||||||
| Net profit | $m | 3 | 2 | -34 | -0 | -1 | 0 | -0 | - |
| EPS reported | $ | 0.00 | -0.00 | ||||||
| Operating cashflow per share | $ | -0.00 | -0.00 | ||||||
| Capex per share | $ | 0.00 | 0.00 | ||||||
| FCF per share | $ | -0.00 | -0.00 | ||||||
| Free cash flow | $m | -0 | -0 | ||||||
| Net debt | $m | -0 | -0 | ||||||
| Book value equity | $m | -0 | -0 | ||||||
| Book value per share | $ | -0.00 | -0.00 | ||||||
| Number of shares | m | 84.6 | 93 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 181.00 | - | ||||||
| P/B LTM | x | -8.11 | -14.41 | ||||||
| P/S LTM | x | 4.78 | 6.78 | ||||||
| P/FCF LTM | x | -11.30 | -10.69 | ||||||
| EV/EBITDA LTM | x | 72.75 | -330.51 | ||||||
| EV/Sales LTM | x | 4.69 | 4.62 | ||||||
| Earnings Yield LTM | % | +0.55% | +0.54% | ||||||
| FCF Yield | % | -8.85% | -9.35% | ||||||
| Quality | |||||||||
| ROE | % | -4.67% | -4.43% | ||||||
| ROIC | % | -3.74% | -3.40% | ||||||
| Operating margin | % | +2.55% | +2.38% | ||||||
| Gross margin | % | +17.51% | +16.82% | ||||||
| FCF/Sales | % | -42.33% | -24.74% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | -75.83% | -82.96% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | - | - | ||||||
| Net Debt/EBITDA | x | -1.46 | -2.60 | ||||||
| EBIT/Net interest | x | 0.00 | 0.00 | ||||||
| Net debt/market cap | % | 0.00% | 0.00% | ||||||
| Net debt/Equity | x | 0.16 | 0.36 | ||||||
| Gross debt/equity | x | -0.00 | -0.00 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
JRSIS Health Care Corporation develops and produces medical technology and equipment in the People's Republic of China. The company develops and markets a multi-faceted smart environment for the retail distribution of pharmaceutical products by pharmacies, hospitals, and online distributors. It offers JM-YF-2000 Automatic Medicine Dispenser, which provides intelligent prompts for high-speed facile human-computer interaction to yield prompt dispensing of medications and batch refilling in the user safety environment. The company was founded in 2018 and is based in Yongzhou, the People's Republic of China.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Not enough data to calculate KvantraRank
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
JRSIS Health Care Corporation develops and produces medical technology and equipment in the People's Republic of China. The company develops and markets a multi-faceted smart environment for the retail distribution of pharmaceutical products by pharmacies, hospitals, and online distributors. It offers JM-YF-2000 Automatic Medicine Dispenser, which provides intelligent prompts for high-speed facile human-computer interaction to yield prompt dispensing of medications and batch refilling in the user safety environment. The company was founded in 2018 and is based in Yongzhou, the People's Republic of China.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free